Singapore markets closed

Atea Pharmaceuticals, Inc. (AVIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7200+0.0200 (+0.54%)
At close: 04:00PM EDT
3.6400 -0.08 (-2.15%)
After hours: 07:26PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
351,367
48,633
Operating expenses
Research development
106,738
114,243
81,936
167,205
38,023
Selling general and administrative
50,750
49,919
48,714
45,785
21,640
Total operating expenses
157,488
164,162
130,650
212,990
59,663
Operating income or loss
-157,488
-164,162
-130,650
138,377
-11,030
Income before tax
-130,431
-134,938
-119,499
138,590
-10,947
Income tax expense
792
1,018
-3,590
17,400
0
Income from continuing operations
-131,223
-135,956
-115,909
121,190
-10,947
Net income
-131,223
-135,956
-115,909
121,190
-10,947
Net income available to common shareholders
-131,223
-135,956
-115,909
121,190
-10,947
Basic EPS
-1.57
-
-1.39
1.46
-0.51
Diluted EPS
-1.57
-
-1.39
1.37
-0.51
Basic average shares
83,353
-
83,245
82,820
21,592
Diluted average shares
83,353
-
83,245
88,249
21,592